Office of Infectious Disease and HIV/AIDS Policy

Office of Infectious Disease and HIV/AIDS Policy is seeking input on potential viral #hepatitis quality measures for implementation at the state and territory level. Quality measures are tools to monitor and improve the quality of health care. Scaling up viral hepatitis screening, linkage to care, and access to treatment will ultimately reduce transmission, incidence of new infections, prevent liver cancer and mortality, and allow the U.S. to make strides in reaching viral hepatitis elimination by 2030. Submit your comments to OIDPViralHepatitis@hhs.gov by 5 p.m. EST on Friday, June 7, 2024. #HepatitisAwarenessMonth #HepAware2024

Healthcare providers! Infant feeding counseling is essential for pregnant and postpartum individuals with #HIV. Make sure you’re up to date on the HIV clinical guidelines for infant feeding so you can assist your patients in understanding their options and work with them to develop and implement an infant feeding plan. Helping people understand their options gives them the power they need to make informed decisions. https://brnw.ch/21wJCqP

America’s HIV Epidemic Analysis Dashboard, as known as AHEAD, is a tool supporting implementation of the Ending the HIV Epidemic in the U.S. (EHE) initiative. The dashboard tracks our nation's progress toward the EHE goals by tracking six key indicators nationally and by EHE jurisdiction. End of
Translation AHEAD also provides links to definitions of the indicators and their data sources, links to other data tools from CDC and HRSA that users can explore, and presents data on seven social determinants of health indicators. How can AHEAD assist your organization? The dashboard can be used to inform local EHE and other HIV-related community planning efforts. Explore the dashboard: https://ahead.hiv.gov/

Vaccination is an important tool in stopping the spread of #mpox! The mpox vaccine can protect against severe illness, hospitalization, and death. JYNNEOS is a 2-dose vaccine developed to protect against mpox and smallpox infections. If you are eligible for the mpox vaccine, it’s important to get both doses of the vaccine. The second dose should be given 4 weeks after the first dose. People who are vaccinated should continue to avoid close, skin-to-skin contact with someone who has mpox. Share information on mpox vaccination from the CDC: https://brnw.ch/21wJAaw

The Health Resources and Services Administration (HRSA) is offering $51 million for HRSA-funded health centers to implement innovative approaches to support transitions in care for people leaving incarceration. OIDP Director Kaye Hayes welcomed Francisco Ruiz, the new Director of the Office of National AIDS Policy (ONAP). Ruiz is the first Latino director of ONAP, and his appointment highlights a commitment to tackling evolving challenges to ending the HIV epidemic. HIVgov coverage of the 2024 Conference on Retroviruses and Opportunistic Infections includes discussions on HIV testing, PrEP, HIV treatment, liver and cardiovascular complications, HIV and aging, vaccine research, ART-free remission, STI post-exposure prophylaxis, syphilis testing, and community-informed research. HIVgov interviewed Nate Fecik, Syndemic Senior Advisor at OIDP, about the importance of defining syndemics for addressing interconnected health issues. Visit HIV.gov to read the full blogs!

To support the nation in making strides toward reaching viral #hepatitis elimination by 2030, the HHS Office of Infectious Disease and HIV/AIDS Policy has been facilitating conversations about the development and adoption of clinically meaningful and feasible state-level viral hepatitis quality measures for Medicaid. Read this brief article for more information about hepatitis, quality measures, and how you can provide feedback. #HepAware24 #HepatitisAwarenessMonth

The Health Resources and Services Administration (HRSA) has announced the availability of $51 million for HRSA-funded health centers to implement innovative approaches to support transitions in care for people leaving incarceration. Get more details in this short article. #Funding

Are you a healthcare provider? The Panel on Treatment of HIV During Pregnancy and Prevention of Perinatal Transmission has updated the Recommendations for the Use of Antiretroviral Drugs During Pregnancy and Interventions to Reduce Perinatal HIV Transmission in the United States. Updates include new data and publications, and incorporation of gender-inclusive language. Learn more: https://brnw.ch/21wJxEi

The 2024 National Latinx Conference on HIV/HCV/SUD (NaLa) will take place from May 2-4, 2024 in El Paso, Texas. The Office of Infectious Disease and HIV/AIDS Policy will be at NaLa! Please stop by the HIV.gov booth to learn about America’s HIV Epidemic Analysis Dashboard (AHEAD) and the "I am a Work of ART"/"Celebro mi salud" campaign. Also stop by the communications lab for technical assistance. __ ¡La Conferencia Nacional Latinx 2024 sobre VIH/VHC/TUS (NaLa, por su sigla en inglés) se llevará a cabo del 2 al 4 de mayo de 2024 en El Paso, Texas. La Office of Infectious Disease and HIV/AIDS Policy estará en NaLa! Pase por el stand de HIV.gov para conocer sobre el Panel de análisis de la epidemia del VIH en los Estados Unidos (AHEAD, por su sigla en inglés) y la campaña "I am a Work of ART"/"Celebro mi salud". También pasa por el laboratorio de comunicaciones para obtener asistencia técnica.

Vaccination is an important tool in stopping the spread of #mpox. If you are eligible for the mpox vaccine, you need to get both doses of the 2-dose JYNNEOS vaccine for the best protection against infection, severe illness, and hospitalization. Share the mpox vaccine locator to help increase mpox vaccination rates: https://brnw.ch/21wJoOM